Oncotarget Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy Bioengineer, 18 Mar 2020 The cover for issue 11 of Oncotarget features Figure 6, “Effects of AZD8186 in combination with anti-PD1 on syngeneic models,…